【摘 要】
:
Objective To evaluate the therapeutic efficacy of transarterial chemoembolization(TACE) with gelatin sponge particles(diameter between 350 to 560μm) in the treatment of hepatocellular carcinoma (HCC).
【机 构】
:
Interventional Therapy Department of Zhongshan Affiliated Hospital of Dalian University China
论文部分内容阅读
Objective To evaluate the therapeutic efficacy of transarterial chemoembolization(TACE) with gelatin sponge particles(diameter between 350 to 560μm) in the treatment of hepatocellular carcinoma (HCC).Methods All of the patients who were treated with gelatin sponge particles with the size of 350~560μm were selected in the international diagnosis standard.The stopping standard is while the arteries of tumor were embolized completely.we recorded the changes of the liver function, AFP, side effects, survival of six months and average survival before embolization Respectively at 4 days and 7 days after treating.Also, the changes of tumor density and size are observed by SCT after the TACE at 4 days and 1 month.Results Forty-nine patients with HCC were enrolled into this study.The diameter of tumor between 10cm to 15cm were 18,12 patients were 15cm to 20cm, and 2 patients were large than 20cm.The nodular were 14 patients and the diffuse were 3 patients.Portal vein tumor thrombus were 6 cases including 2 cases involved trunk, 2 cases transfer to lung, and 1 was dead in myocardial infarction.the total of TACE treatment were 162 times, the average number of treatments were 3.3.After the follow-up from 2.5 months to 2 years.Survival less than 6 months were 6 cases.4 and 7 days After TACE, TB: 38.60±a18.47 u mol/l、 28.36 ±12.24 u mol/l、 ALT: 150.96±55.17 U/L、 84.03±18.38 U/L.ALB:29.13±5.98g/l、 32.50±6.08 g/l.Forty-six patients had CT scan examination 4 days after embolization,100% cases of the tumor density were significantly declined, 92.5% cases were mostly cellular necrosis.Side effects: 100% cases of stomach discomfort and 1 case of liver abscess.Conclusion Our experience in HCC patients treated with gelatin sponge particles alone combined with chemoembolization had shown that it was a safe and effective treatment with no serious damage to liver and side effects.
其他文献
In 2006, an Enhanced Recovery After Surgery (ERAS) Program was introduced for colorectal resections at the Coifs Harbour Health Campus, a 200 bed hospital in northern New South Wales.This was followin
Colorectal cancer (CRC) has become one of the leading causes of cancer-related deaths in Hong Kong.The overactive Wnt/β-catenin signaling may contribute to colorectal carcinogenesis by promoting proli
Cervical cancer screening has been introduced in Botswana free of charge to all at risk women attending government hospitals in 2003.Despite this step by the govemment, the uptake of cervical cancer h
Chemoradiation is the mainstay of treatment management for locally advanced cervical cancer.Delivery of treatment to these advanced cervical cancers can be challenging given loss of normal landmarks.I
The IL23R gene on chromosome 1p31 encodes a subunit of the receptor for the proinflammatory cytokine interleukin23.Recently, IL23R could be identified as a novel inflammatory bowel disease susceptibil
Essential Thrombocytosis (ET), Polycythemia Vera (PV), Primary Myelofibrosis (PMF) belong to the Philadelphia chromosome negative myeloproliferative neoplasms (Ph negative MPNs) according to the WHO c
Increase of targeted anticancer therapies led to the beginning of a new era of cancer treatment, partly instead of classical chemotherapies, partly supplementing these.While for a number of substances
The cancer staging system developed by the American Joint Committee on Cancer (AJCC) is now recognized as the worldwide "language of cancer" for use by the medical profession for selecting the most ap
The current treatment for metastatic gastric cancer is ineffective because of the poor prognosis and the development of resistance against chemotherapeutic drugs.Hence, new agents that are safe and ef
This presentation describes an epithelial myoepithelial carcinoma (EMEC) of the parotid gland.EMECs are unusual and rare tumors that make up less than 1% of salivary gland neoplasms.They tend to show